Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2009; 53:709-717, doi:10.1016/j.jacc.2008.11.014
© 2009 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Takahama, H.
Right arrow Articles by Kitakaze, M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Takahama, H.
Right arrow Articles by Kitakaze, M.
Related Collections
Right arrowRelated Articles

PRE-CLINICAL RESEARCH

Prolonged Targeting of Ischemic/Reperfused Myocardium by Liposomal Adenosine Augments Cardioprotection in Rats

Hiroyuki Takahama, MD*,{dagger},{ddagger}, Tetsuo Minamino, MD, PhD§,*, Hiroshi Asanuma, MD, PhD{dagger}, Masashi Fujita, MD, PhD§, Tomohiro Asai, PhD, Masakatsu Wakeno, MD, PhD*,{dagger},{ddagger}, Hideyuki Sasaki, MD*,{dagger},{ddagger}, Hiroshi Kikuchi, PhD#, Kouichi Hashimoto**, Naoto Oku, PhD, Masanori Asakura, MD, PhD{dagger}, Jiyoong Kim, MD{dagger}, Seiji Takashima, MD, PhD§, Kazuo Komamura, MD, PhD||, Masaru Sugimachi, MD, PhD||, Naoki Mochizuki, MD, PhD*,{ddagger} and Masafumi Kitakaze, MD, PhD, FACC{dagger}

* Department of Molecular Imaging in Cardiovascular Medicine, Osaka University Graduate School of Medicine, Osaka, Japan
{dagger} Department of Cardiovascular Medicine, National Cardiovascular Center, Osaka, Japan
{ddagger} Department of Structural Analysis, Research Institute, National Cardiovascular Center, Osaka, Japan
§ Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, Osaka, Japan
|| Department of Cardiovascular Dynamics, Research Institute, National Cardiovascular Center, Osaka, Japan
Department of Medical Biochemistry, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan
# Daiichi Pharmaceutical Co., Tokyo, Japan
** Daiichi-Sankyo Pharmaceutical Co., Tokyo, Japan

Manuscript received September 4, 2008; revised manuscript received October 21, 2008, accepted November 3, 2008.

* Reprint requests and correspondence: Dr. Tetsuo Minamino, Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan (Email: minamino{at}medone.med.osaka-u.ac.jp).

Objectives: The purpose of this study was to investigate whether liposomal adenosine has stronger cardioprotective effects and fewer side effects than free adenosine.

Background: Liposomes are nanoparticles that can deliver various agents to target tissues and delay degradation of these agents. Liposomes coated with polyethylene glycol (PEG) prolong the residence time of drugs in the blood. Although adenosine reduces the myocardial infarct (MI) size in clinical trials, it also causes hypotension and bradycardia.

Methods: We prepared PEGylated liposomal adenosine (mean diameter 134 ± 21 nm) by the hydration method. In rats, we evaluated the myocardial accumulation of liposomes and MI size at 3 h after 30 min of ischemia followed by reperfusion.

Results: The electron microscopy and ex vivo bioluminescence imaging showed the specific accumulation of liposomes in ischemic/reperfused myocardium. Investigation of radioisotope-labeled adenosine encapsulated in PEGylated liposomes revealed a prolonged blood residence time. An intravenous infusion of PEGylated liposomal adenosine (450 µg/kg/min) had a weaker effect on blood pressure and heart rate than the corresponding dose of free adenosine. An intravenous infusion of PEGylated liposomal adenosine (450 µg/kg/min) for 10 min from 5 min before the onset of reperfusion significantly reduced MI size (29.5 ± 6.5%) compared with an infusion of saline (53.2 ± 3.5%, p < 0.05). The antagonist of adenosine A1, A2a, A2b, or A3 subtype receptor blocked cardioprotection observed in the PEGylated liposomal adenosine-treated group.

Conclusions: An infusion as PEGylated liposomes augmented the cardioprotective effects of adenosine against ischemia/reperfusion injury and reduced its unfavorable hemodynamic effects. Liposomes are promising for developing new treatments for acute MI.

Key Words: myocardial infarction • liposome • drug delivery system • adenosine

Abbreviations and Acronyms
  8-SPT = 8-(p-sulfophenyl) theophylline
  EM = electron microscopy
  MI = myocardial infarction
  PEG = polyethylene glycol
  RI = radioisotope
  TTC = triphenyltetrazolium chloride


Related Articles

Adenosine at Reperfusion: A Conundrum Ready to Be Resolved
Michael V. Cohen and James M. Downey
J. Am. Coll. Cardiol. 2009 53: 718-719. [Full Text] [PDF]

Inside This Issue
J. Am. Coll. Cardiol. 2009 53: A21-A24. [Full Text] [PDF]



This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
M. V. Cohen and J. M. Downey
Adenosine at reperfusion a conundrum ready to be resolved.
J. Am. Coll. Cardiol., February 24, 2009; 53(8): 718 - 719.
[Full Text] [PDF]



 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement